MedTrace Logo

An Open-label, Single Dose Pharmacokinetic Study of 14 mg Granisetron Patch in Healthy Subjects

NCT00954291 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2010-09-06

No results posted yet for this study

Summary

The objective of the study is to characterize the pharmacokinetic profile of granisetron patch after single administration to healthy subjects.

Conditions

Sponsors & Collaborators

  • Taipei Medical University WanFang Hospital

    lead OTHER

Principal Investigators

  • Hsingjin E Liu, M.D., Ph.D. · Taipei Medical University - Municipal Wan Fang Hospital

Eligibility

Min Age
20 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-07-31
Primary Completion
2009-08-31
Completion
2009-08-31

Countries

  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00954291 on ClinicalTrials.gov